Ampakine CX717 improves delayed match to sample performance

Posted by Neville Sanjana at 1:21 AM EST

Scientific Clearing House: Mind enhancing drugs

Apparently, CX717, an ampakine developed by Cortex Pharmaceuticals, shows some signs of preventing the cognitive impairment brought on by sleep deprivation. The original study in PLoS Biology (news & views) was done with monkeys.

One Response to “Ampakine CX717 improves delayed match to sample performance”

  1. neurodudes » Blog Archive » CX717: Preventing sleep deprivation trauma Says:

    [...] More information about the ampakine CX717 can be found here. We previously mentioned the delay match-to-sample performance improvement of monkeys on CX717. [...]

Leave a Reply

 

Additional comments powered by BackType

  • nd categories

  • contact us

    Neurodudes is moderated by Neville Sanjana, Bayle Shanks, and Stephen Larson. Comments that you post might be delayed so that we can tell our software that it's not spam -- however, not all comments are pre-screened so don't assume that we have read them, either. Any money we make off this site is used to pay for hosting, or given to charity; if in the future we pay contributors, we will include reader-authors. None of us are medical doctors so please don't ask for medical advice. Contact us here.